September 29, 2026
Link Cell Therapies
Link Cell Therapies, a biotechnology company, raised an additional $30 million, upsizing its Series A round to $90 million.
- Round
- Series A
- Amount raised
- $30M
- Lead investor
- Johnson & Johnson Innovation – JJDC, Inc.
- Industry
- Biotechnology
- Headquarters
- United States
- Employees
- —
- Website
- api.whatsapp.com
- —
Source: FinSMEs